One proposed biological mechanism by which intronic FTO SNPs may increase T2D risk is through their influence on the expression of adjacent genes, IRX3 and IRX5, which modulate brown adipocyte differentiation [34,35], as well as through appetite regulation via the hypothalamus [36,37]. This evidence concerns the gene IRX5 and type 2 diabetes mellitus.